Technology & Innovation
Breakthrough Research
At Oncovara Pharmaceuticals, innovation isn’t just a value it’s our foundation. As a pioneering cancer research company, we are developing a new class of proprietary molecules designed to outsmart some of the deadliest and most treatment-resistant cancers.
Our technology platform fuses cutting-edge science, data-driven discovery, and molecular ingenuity to create therapies with transformational potential.
Emmanuel Kiyonga
Oncovara Co-Founder
Research Awards & Achievements
• First Registered Patent at SMU – Lead inventor of the Raloxifene
Hydrochloride Solvate Hydrate patent.
• Winner, Young Scientist Award (APSSA 2023) – Recognised for research
excellence at the 42nd APSSA National Conference.
• Recipient, Technology Innovation Agency (TIA) Seed Fund (2023) –
Supported research innovation for commercialisation.
• Winner, Postgraduate Podium Presentation, SMU Research Day 2023.
• Entrepreneurship Development in Higher Education (EDHE) Intervarsity
2024 – Overall Winner & Research-Based Business Category Winner.
